12/14/2021 Dr. Paul T. Finger has been inducted into the Retina Hall of Fame! The Eye Care Foundation is proud to congratulate our Founder and Chairman, Dr. Paul T. Finger on being inducted into the Retina Hall of Fame! In 1998, Paul T. Finger, MD established The Eye Cancer Foundation as an educational and supportive...
11/24/2021 Dr. Yacoub Yousef receives the King Hussein Award for Excellence in Cancer Research! Dr. Yousef, a Senior Fellow and of The Eye Cancer Foundation was trained by Drs. Paul T Finger and Brenda Gallie. Today, we are pleased to announce that he was awarded the King Hussein Award or Excellence in Cancer...
11/12/2021 Springer Publishers has Reported The Eye Cancer Foundation Sponsored Open-Access Eye Cancer Surgery Textbook to be More Popular than Expected! At the 2014, ECF-sponsored First Eye Cancer Working Day (Curie Institute, Paris France), Drs. Finger and Santosh Honavar suggested that an open-access...
10/18/2021 The ECF has sponsored another fellow who has completed their Ophthalmic Oncology Training in Cambodia! Cambodian fellow, Lom Orng Kiry, MD was one of the few successful ECF candidates to complete a fellowship during the devastating time of Covid-19. She travelled to India and was trained by our Scientific Board..
09/27/2021 An ECF fellow, Dr. Gaurav Garg, has been selected for the Best Abstract (Free Paper) Award Dr. Garg's paper on Patients Presenting with Metastases: Stage IV Uveal Melanoma, an International Study, has recently been selected for Best Free Paper Award for Asia Pacific Vitreo-retina Society (APVRS) 2021. This...
09/16/2021 OCT-A evaluation of radiation vasculopathy following slotted plaque brachytherapy A new non-invasive technology called, Optical Coherence Tomography Angiography or OCTA, can image the very small retinal blood vessels without contrast dye. Drs. Paul T. Finger, Dr. Anthony Fam & Dr. Ankit Tomar’s research to seen if...
09/09/2021 New Intravitreal Injection Methods Dr. Finger wrote this lecture to share this experience with intravitreal injections. Since he first used intraviteral anti-VEGF agents for the treatment of radiation maculopathy and optic neuropathy, there has been quite an evolution of his intravitreal methods. Most methods for...
08/03/2021 AJCC 8th edition TNMH Retinoblastoma Staging: The One Multi-Purpose Staging System Funded by The Myrna and John Daniels Family, The Paul Finger Fund and The Eye Cancer Foundation, an internet-based data-research repository was created to evaluate the American Joint Committee on...
07/06/2021 Donor Generosity Provides Ophthalmology Equipment For Our Fellowship Program Graduate Due to the generosity of our Board Member, Ms. Lynne Shevlin, The Eye Cancer Foundation was able to send a state-of-the-art indirect ophthalmoscope to one of our eye cancer fellows, in the Philip...
06/27/2021 The All India Ophthalmological Meeting: Keynote Speaker, Dr. Paul Finger In 2003, I was selected to chair the 7th All India Ophthalmological Meeting edition American Joint Committee on Cancer's -AJCC effort for ophthalmic oncology.I knew that the 6th edition was not being used, so I created the AJCC...
06/11/2021 Presenting The Spring 2021 Visionary The Spring 2021 issue of The Eye Cancer Foundation's Visionary magazine is now available! The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research and global efforts focused on improving eye cancer...
06/11/2021 The Eye Cancer Foundation Awarded 2021 Platinum Seal of Transparency by GuideStar For the second year in a row, The Eye Cancer Foundation has been awarded the Platinum Seal of Transparency by GuideStar, the leading source of information on non-profits within the United States. The ECF is pleased that...
05/19/2021 Patient Story: Eye Saved From Enucleation Through Eye Cancer Network It comes as no question eye cancer care is not readily available in all corners of the world, hence the work and mission of The Eye Cancer Foundation. This is especially true of countries in the Middle East, where more aggressive forms...
05/13/2021 ECF Supported Research Featured in New York Eye and Ear Infirmary 200 Years Celebration The New York Eye and Ear Infirmary of Mount Sinai is celebrating 200 years of providing innovative, first-class care to patients with ocular diseases. At the core of the infirmary's Ocular Oncology...
04/05/2021 Patients Presenting with Stage IV Metastatic Uveal Melanoma Examined in New ECF Supported Study Uveal melanoma is classified as Stage IV when there are metastasis. A multi-center, international collaborative registry study was recently published in the British Journal of Ophthalmology...
03/29/2021 The ECF Sponsors New Study Assessing Ophthalmic Radiation Therapy Outcomes Alongside the Myrna and John Daniels Fund at the Princess Margaret Cancer Center, The Eye Cancer Foundation is proud to co-sponsor the Study of Ophthalmic Radiation Therapy Toxicity (SORTT). Through the international...
03/18/2021 Ciliary Body Leiomyoma and Melanoma Can Appear Identical as Found in Research Supported by The Eye Cancer Foundation In a new study published to the American Journal of Ophthalmology Case Reports, eye cancer professionals identified biopsy with immunohistochemical pathology analysis as the only...
01/15/2021 The ECF Recognizes Recently Published Research on Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma In a recent study published in Clinical Ophthalmology, eye care specialists examined conservative routes of treatment for group D retinoblastoma patients, As its...
11/13/2020 Meet ECF Board Member, Anne Marie! Meet one of our Board Members, Anne Marie Montijo! Anne Marie Montijo has been a part of The Eye Cancer Foundation's Board of Directors since 2008 and a force for patient care since 2006. Anne Marie has led our patient support services, having organized many patient...
10/22/2020 Meet The ECF's Development Director! Meet our Development Director, Henry Ackermann! Over the course of the past 20 years, The Eye Cancer Foundation has worked diligently to advance eye cancer care around the world. In addition to our generous supporters, it takes a team of professionals who are well...
